Peter J. Tonge, Ph.D.
|Academic Units and Collaborating Faculty:||Biochemistry & Cell Biology||Jarod French
|Pharmacological Sciences||Michael Frohman|
|Neurobiology & Behavior||Lorna Role|
Imaging biological molecules at the molecular level is the key step in understanding their function and interactions with other biomolecules, providing a starting point for the design of drugs that bind to a bimolecular target to prevent or treat cancer and infections. With the new faculty who will be hired in the cluster, recent investments in NMR facilities at Stony Brook, and the proximity to the new National Synchrotron Light Souce II at Brookhaven National Laboratory, Stony Brook is poised to become a world leader in imaging of biological materials at the molecular level. In total, we will recruit five junior faculty whose research interests span a range of imaging modalities, including NMR spectroscopy, X-ray crystallography, ultrahigh resolution light microscopy, cryoelectron microscopy, and positron emission tomography coupled with radiotracer synthesis. Academic appointments for cluster faculty will be based on their areas of research, and will be in the Departments of Biochemistry and Cell Biology, Chemistry, Pharmacological Sciences, and/or Neurobiology and Behavior. This cluster initiative is spearheaded by Dr. Peter Tonge, Director of Infectious Disease Research, in the Institute for Chemical Biology and Drug Discovery, Director of the Translational Experimental Therapeutics Laboratory, and Professor with Stony Brook's Department of Chemistry.
More information on Biomolecular Imaging Cluster can be found on the cluster webpage at http://www.stonybrook.edu/commcms/clusterhires_bmi/.